Panacea Biotech-A high risk, huge reward stock!
Panacea biotech is in news for developing Dengue vaccine.
Technically, stock has bounced from support trendline and is looking strong to test ATH levels once again which can be around 2x from CMP.
Keep in watchlist. A very risky volatile stock and is not a recommendation.
Technically, stock has bounced from support trendline and is looking strong to test ATH levels once again which can be around 2x from CMP.
Keep in watchlist. A very risky volatile stock and is not a recommendation.
Note
300+ done from 240. T1 will be hit very soon!Trade active
T2 done as well. T3 approachingTrade closed: target reached
T3 done and dusted. 2x done!
remove capital and hold for multibagger returns if interested.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.